Back
Sarepta Therapeutics Vs. Nike Industry Stock Comparison
Buy
63
SRPT
Sarepta Therapeutics
Last Price:
153.17
Seasonality Move:
21.71%
Sell
17
NKE
Nike
Last Price:
75.29
Seasonality Move:
6.25%
Buy
63
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $154.20. The Score for SRPT is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
17
Nike (NKE)
is a Sell
Is Nike a Buy, Sell or Hold?
- The current Nike [NKE] share price is $76.04. The Score for NKE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- NKE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $154.20
The current trend is moderately bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
NKE Stock Price Chart
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.88 | Buy |
| Relative Strength Index (14 RSI): | 64.49 | Buy |
| Chaikin Money Flow: | -835889 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (115.27 - 150.69) | Buy |
| Bollinger Bands (100): | (118.39 - 139.07) | Buy |
NKE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.2 | Sell |
| Relative Strength Index (14 RSI): | 21.68 | Sell |
| Chaikin Money Flow: | -4026097 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (86.28 - 98.68) | Sell |
| Bollinger Bands (100): | (89.69 - 101.25) | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 158.27 | Sell |
| 20-day SMA: | 135.81 | Buy |
| 50-day SMA: | 131.14 | Buy |
| 200-day SMA: | 116.2 | Buy |
| 8-day EMA: | 152.26 | Buy |
| 20-day EMA: | 141.95 | Buy |
| 50-day EMA: | 133.41 | Buy |
| 200-day EMA: | 122.08 | Buy |
NKE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 88.2 | Sell |
| 20-day SMA: | 92.27 | Sell |
| 50-day SMA: | 92.61 | Sell |
| 200-day SMA: | 100.01 | Sell |
| 8-day EMA: | 85 | Sell |
| 20-day EMA: | 89.87 | Sell |
| 50-day EMA: | 92.49 | Sell |
| 200-day EMA: | 99.26 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
Nike Earnings Growth & NKE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.48 per share, and a decrease next year of $0.52 per share.
Sarepta Therapeutics Technical Analysis
| Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nike Technical Analysis
| Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||